Delivery Order SPE2DB22D3501-SPE2DB24FUY19
Award Date 3/15/24
Potential Completion Date 4/5/24
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product, with a ceiling value of $8,016.30 and a performance period through May 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. The company...
- The Defense Logistics Agency awarded a delivery order valued at $9,344.66 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 ml vials on January 28, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by February 19, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. This contract represents a task order under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,018.40 contract is for the supply of 840 mg/14 ml vials of the cancer medication Tecentriq. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies in support of military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,504.62 on September 19, 2025, for the supply of Tecentriq 840 mg/14 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of October 10, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside award made through open competition, reflecting AmerisourceBergen's demonstrated capability to fulfill...
- The Defense Logistics Agency awarded a $17,009.24 delivery order to AmerisourceBergen Drug Corp for Tecentriq 840 mg/14 ml vials on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major distribution hub for federal pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 840 mg/14 mL vials of the drug TECENTRIQ. The contract has a potential value of $24,048.90 and a period of performance through March 25, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which does not have any set-aside designation. Additionally,...
- The Defense Logistics Agency issued a $9,344.66 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Tecentriq 840 mg/14 ml vial pharmaceutical product. The order is a call against an Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a vast range of pharmaceutical products and medical supplies to support military healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $8,962.54 to AmerisourceBergen Drug Corp for Tecentriq 840 mg/14 mL vials on December 16, 2025. This competitively awarded, firm fixed-price contract is scheduled for completion by January 8, 2026, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. Tecentriq is a specialized oncology medication used in cancer treatment protocols, reflecting the Defense Logistics Agency's role in supplying...
- The Defense Logistics Agency awarded a delivery order valued at $28,033.98 to AmerisourceBergen Drug Corp for the supply of Tecentriq (atezolizumab) 840 mg/14 mL vials on January 6, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price, non-competitive award was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TECENTRIQ HYBREZA 1,875 MG 15ML, a medical product, with a ceiling value of $6,297.24 and a period of performance ending on July 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...